Study Assessing the Reduction of Pain Felt During Installation Intra- Uterine Device by Direct Technique (DIRECTE)

Comparative Study, Prospective, Randomized , Assessing the Reduction of Pain Felt During Installation Intra- Uterine Device by Direct Technique. A Monocentric Study

Intrauterine devices (IUDs) are contraceptive methods of long-acting (from 3 to 10 years depending on the model) and among the most effective. However, there are many obstacles to the use of IUDs including pain felt by patients during installation. Several medical means were studied without evidence of their efficacy in pain related to IUD insertion. In order to remove this brake, it's important to find another way to act against this pain. The direct technique is one of the techniques described by health professionals. It seems trusted by its users as a more reliable technique but also less painful for patients. However, there is no study available on its evaluation. The aim of this study is to investigate the interest of the direct technique in reducing the pain experienced by patients during installation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Etienne, France, 42055
        • CHU Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Any major patient and consultant for IUD insertion : hormonal or copper
  • Signing of the information and consent form by the patient or, if under supervision by parents or guardian.
  • Patient affiliated with or entitled to a social security scheme
  • No contraindication for IUD insertion

Exclusion Criteria:

  • Patient consultant for IUD insertion to side arms
  • Contraindications for installation.
  • Legal incapacity or limited legal capacity. Medical or psychological conditions not allowing the subject to understand the study and sign the consent
  • Refusal to sign the consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Conventional technique
Intrauterine device (IUD) insertion by the conventional technique
copper IUD or levonogestrel IUD insert by the conventional technique or by direct technique
Experimental: Direct technique
Intrauterine device (IUD) insertion by the direct technique
copper IUD or levonogestrel IUD insert by the conventional technique or by direct technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain measured by Verbal Numeric Scale
Time Frame: intraoperative
Pain is score by Verbal Numeric Scale : 0-10 (0 = no pain; 10= pain as bad as can be)
intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of failure laying direct technique
Time Frame: intraoperative
intraoperative
Number of vagal discomfort
Time Frame: intraoperative
intraoperative
Number of expulsion of the IUD
Time Frame: intraoperative
intraoperative
Number of IUD-fond uterine distance >2 cm
Time Frame: intraoperative
intraoperative
Number of expulsion of IUD
Time Frame: up to 7 days
up to 7 days
Number of emergency department visit for a IUD complication
Time Frame: up to 7 days
up to 7 days
Number of analgesic intake
Time Frame: up to 7 days post-insertion
up to 7 days post-insertion
Pain measured by Verbal Numeric Scale
Time Frame: day 1
Pain is score by Verbal Numeric Scale : 0-10 (0 = no pain; 10= pain as bad as can be)
day 1
Pain measured by Verbal Numeric Scale
Time Frame: day 7
Pain is score by Verbal Numeric Scale : 0-10 (0 = no pain; 10= pain as bad as can be)
day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 24, 2016

Primary Completion (Actual)

July 12, 2017

Study Completion (Actual)

July 19, 2017

Study Registration Dates

First Submitted

November 2, 2015

First Submitted That Met QC Criteria

November 2, 2015

First Posted (Estimate)

November 3, 2015

Study Record Updates

Last Update Posted (Actual)

January 29, 2018

Last Update Submitted That Met QC Criteria

January 26, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 1508153
  • 2015-A01966-43 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraception

Clinical Trials on IUD

3
Subscribe